Comparing Effectiveness and Outcomes in Asthma and Cystic Fibrosis

As technology yields new treatments, pediatric pulmonologists need determine how best to use them and how to decide which ones are best for any specific group or individual patient. Physicians have always customized therapies based upon patient response, but the new concept of “Personalized (or precision) medicine” focuses attention to a greater degree on the individual needs of patients based on their genetic, biomarker, phenotypic, or psychosocial characteristics. The newly developed biologics for treatment of asthma and CFTR modulators for treatment of cystic fibro sis (CF) highlight this newer approach.
Source: Paediatric Respiratory Reviews - Category: Respiratory Medicine Authors: Tags: Mini-symposium Source Type: research